Wonbiogen registers wound dressing products with US FDA

Wonbiogen completed US FDA registration for hydrocolloid wound dressing products, enabling export expansion to North America. The company is negotiating supply contracts with US companies and plans to build a dedicated production plant.

“With this US FDA registration as the starting point, our export activities to North America will expand further, laying the foundation for future growth.”asiae.co.kr

• 1 source
• asiae.co.krWonbiogen Registers Wound Dressing Product with US FDA... "Expanding Export Opportunities" - The Asia Business DailyRyu HyunseokJun 7, 2021

Summarized from public sources; check the original articles before acting on it.